The euro is in negative territory at the start of the new trading week. EUR/USD is trading around 1.1320 in the European session. Investment confidence up, unemployment down The week kicked off with positive European Read more…
The major currency pair is falling after demonstrating some growth last week. The asset is mostly trading at 1.1330. Market players are still processing the FOMC Meeting Minutes published last Wednesday. The document says that Read more…
Wall Street looks set to extend last week’s declines, with tech stocks leading to the downside, ahead of a key reading of December inflation, Jerome Powell testimony and the start of the fourth quarter earnings Read more…
EURUSD was higher on Friday, but stopped at key 78.6% Fib resistance so for now bearish interpretation is still valid and it may produce a really strong breakdown if we see a new impulse down Read more…
Grand Theft Auto maker Take-Two will pay $9.86 per share for Zynga in a deal that values the social gaming group at around $12.7 billion. Take-Two Interactive (TTWO) – Get Take-Two Interactive Software, Inc. Report said Read more…
The cryptocurrency market received moderate support from retail buyers over the weekend. Over the past 24 hours, the capitalisation of all coins rose 0.22%, according to CoinMarketCap, approaching $1.97 trillion. The top altcoins lost 11-19% Read more…
Lululemon said staff shortages and reduced store hours would likely drag fourth quarter profits to the lower end of its previously-published guidance. Lululemon Athletica (LULU) – Get Lululemon Athletica Inc Report shares slumped lower Monday after the Read more…
Ford is warning it will literally pull the plug on any dealer that tries to cut a side-deal and take extra cash for the new Lightening F-150 all-electric pickup. Don’t even think about it, or Read more…
Part I: Are Cryptocurrencies Really “Money”? Summary The form that money takes has evolved over the centuries. Most recently, fiat money and bank deposits replaced gold and other precious metals as the predominant form of Read more…
Boston-based Beam Therapeutics has agreed to a potential $1.35 billion drug development deal with pharma giant Pfizer. Pfizer Inc. (PFE) – Get Pfizer Inc. Report said Monday it has formed a research collaboration with Beam Therapeutics Read more…